Davis Robert M 4
4 · Merck & Co., Inc. · Filed May 1, 2025
Insider Transaction Report
Form 4
Davis Robert M
DirectorChairman, CEO & President
Transactions
- Award
Stock Option (Right to Buy)
2025-04-29+181,623→ 181,623 totalExercise: $84.71From: 2026-04-29Exp: 2035-04-28→ Common Stock (181,623 underlying) - Award
Restricted Stock Unit
2025-04-29+39,901→ 39,901 totalFrom: 2026-04-29Exp: 2028-04-29→ Common Stock (39,901 underlying)
Holdings
- 443,601.757
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F2]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
- [F3]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.